2Renzi C, Douglas JM Jr Foster M, et al. Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis. 2003,187 (1) :19 -25.
3Wald A, Corey L. How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis? J Infect Dis. 2003,187 (10):1509-1512.
4Landolfi V, Zarley CD, Abramovitz, et al. Baculovirus-expression herpes simplex virus type 2 glycoprotein D is immunogenic and protective against lethal HSV challenge. Vaccine, 1993,11 (4): 407 -414.
5van Kooij A, Middel J, Jakab F, et al. High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 2002, 25 (3) : 400 - 408.
6Whitbeck JC, Muggeridge MI, Rux AH, et al. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain. J Virol, 1999, 73 ( 12): 9879 - 9890.
